01 1Biocon
01 1LENALIDOMIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-10
Pay. Date : 2020-07-17
DMF Number : 34956
Submission : 2020-07-31
Status : Active
Type : II
20
Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LENALIDOMIDE, with a corresponding US DMF Number 34956.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2020, and payment made on July 17, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
